Purification of a yeast TATA box-binding protein that exhibits human transcription factor IID activity

Proc Natl Acad Sci U S A. 1989 Jul;86(13):4843-7. doi: 10.1073/pnas.86.13.4843.

Abstract

By a series of conventional chromatographic procedures we have purified from whole-cell extracts of Saccharomyces cerevisiae yeast transcription factor IID (TFIID), which functionally substitutes for human TFIID in a complementation assay comprised of the adenovirus type 2 major late promoter and HeLa cell-derived RNA polymerase II, transcription factors IIA, IIB, and IIE. Similar to its human counterpart, yeast TFIID also exhibited specific binding to the adenovirus type 2 major late promoter TATA element, as shown by both DNase I footprinting and gel mobility shift assays. NaDodSO4/PAGE analyses showed that a 27-kDa polypeptide coeluted with TFIID complementing activity through each chromatographic step. In agreement with this result and also suggesting that the native protein is a monomer, gel-filtration experiments indicated a molecular mass of 28 kDa for TFIID under nondenaturing conditions. That the 27-kDa polypeptide represented TFIID was further demonstrated by the ability of an HPLC-purified protein to bind specifically after renaturation to the adenovirus type 2 major late promoter TATA sequence.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Neoplasm*
  • Base Sequence
  • Chromatography, Affinity
  • Chromatography, Gel
  • Fagopyrum / immunology
  • Fagopyrum / metabolism*
  • HeLa Cells / metabolism
  • Histocompatibility Antigens*
  • Humans
  • Kinetics
  • Molecular Weight
  • Promoter Regions, Genetic
  • Saccharomyces cerevisiae / genetics
  • Saccharomyces cerevisiae / metabolism*
  • Transcription Factor TFIID
  • Transcription Factors / metabolism*
  • Transcription, Genetic

Substances

  • Antigens, Neoplasm
  • Histocompatibility Antigens
  • Transcription Factor TFIID
  • Transcription Factors
  • tumor-associated transplantation antigen